Cross-linked CMC and Silk Proteins in Eye Disease

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Dry Eye Disease (DED)
Interventions
DEVICE

CX-HA and CS

Sterile Isotonic ophthalmic solution

Trial Locations (1)

00184

San Giovanni-Addolorata Hospital, Rome

All Listed Sponsors
collaborator

San Giovanni Addolorata Hospital

OTHER

lead

D&V FARMA srl

INDUSTRY

NCT06605365 - Cross-linked CMC and Silk Proteins in Eye Disease | Biotech Hunter | Biotech Hunter